CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74-89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please refer to our Risk Disclosure Statement
Open platformOpen platform

BriaCell Reports Sustained Cancer-Cell Killing With Bria-OTS+ in Preclinical Studies

By Public Technologies
  • BriaCell Therapeutics and majority-owned BriaPro announced preclinical immunotherapy findings for presentation in four posters at SITC on Nov. 6-7, 2026.
  • Bria-OTS+ activated immune responses across multiple cancer models, with sustained cancer-cell killing supporting continued development in breast and prostate cancers.
  • BriaPro's BP-80 was well tolerated in a nonhuman primate study, with no treatment-related pathological findings.
  • TILsRx-001 counteracted immune inhibition in laboratory testing; engineered CD80 variants showed stronger binding to a checkpoint target, supporting further development.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Briacell Therapeutics Corp. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611060900PRIMZONEFULLFEED9872089) on November 06, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk